← Eichor
Condition: Dyskeratosis Congenita Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dyskeratosis Congenita

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07628972
Nucleoside Therapy in Patients With Telomere Biology Disorders
Phase 1 · 1 location(s) · Suneet Agarwal · NCT06817590
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03579875
Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268
Cancer in Inherited Bone Marrow Failure Syndromes
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT00027274
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failu
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04232085
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415
Investigation of the Genetics of Hematologic Diseases
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT02720679
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.